Alkermes Announces Approval Of VIVITROL(R) For The Treatment Of Alcohol Dependence In Russia
admin Alkermes, Inc. (NASDAQ: ALKS) declared that its partner, Cilag GmbH International, a supplementary of President & Johnson, conventional support from the Slavonic Regulatory Authorities to mart VIVITROL® (naltrexone for extended-release injectable suspension) for the communication of beverage dependency in Russia. The creation module be manufactured by Alkermes and commercial by Janssen-Cilag, an affiliate consort of Cilag GmbH International.
Tags: Alcohol, Alcohol Dependence, ATM, Subsidiary
Posted in Addiction |